This joint guidance by the ECDC and EMCDDA aims to strengthen the evidence base for developing national strategies for preventing and controlling infections and infectious diseases among people who inject drugs.
Haemophilus influenzae type b (Hib) is an obligate human pathogen and an important cause of invasive bacterial infections in both children and adults, with the highest incidence among young children.
Despite good access to effective antibiotics, Streptococcus pneumoniae (pneumococci) is still a major cause of disease and death in both developing and developed countries. Pneumococci are the main cause of bacterial respiratory tract infections, such as pneumonia, middle ear infection, and sinusitis, in all age groups.
This document is an update of the joint guidance that was published in 2011 by the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 22-28 October 2023 and includes updates on poliomyelitis, SARS-CoV-2, West Nile virus, the Rugby World Cup 2023, and cryptosporidiosis cases.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 15-22 October 2023 and includes updates on respiratory virus epidemiology in the EU/EEA, SARS-CoV-2 variant classification, cryptosporidiosis, dengue, West Nile virus, and mass gathering monitoring for the Rugby World Cup.